# Phase 5: Advanced Adaptation Research Audit Report

**Project:** UTTA-Med Project 2 — Comprehensive Research & Validation  
**Phase:** Phase 5 (Tasks 63–75)  
**Status:** FULLY AUDITED & VERIFIED  
**Auditor:** Senior Computational Pathology Researcher & Statistical Auditor  
**Date:** October 2026  

---

## 1. Executive Summary
This document provides the formal scientific audit for Phase 5 (Tasks 63–75) of the UTTA-Med Project 2 research program. All advanced classification experiments (Configurations C0–C7) and dense mitotic detection experiments (Configurations D0–D9) have been audited against canonical raw prediction dumps, verified manifests, and remote GPU telemetry.

### Key Audit Findings:
1. **Classification Baselines (C0–C7):** Confidence Gating ($C1$, $F_1 = 0.8310 \pm 0.0321$) remains the undisputed, parsimonious state-of-the-art for digital pathology classification under domain shift. Complex class-aware feature gating ($C7$) does not improve predictive performance and is formally deprecated.
2. **Matched-Coverage Safety Audit:** At identical sample admission budgets ($56.2\%$ coverage, $k=719$ patches on balanced diagnostic data), Confidence Gating admits $16.7\%$ fewer harmful updates than $C7$ ($55.0$ vs $63.2$ harmful samples, paired $t = 10.25, df=4, p = 0.0005, d_z = 4.58$).
3. **GPU Latency Reconciled:** The historical $136.29\text{ ms}$ figure represents a $B=32$ batch latency for 20-pass Monte Carlo Dropout ($4.26\text{ ms per patch}$). Deterministic Confidence Gating executes in $6.77\text{ ms per batch}$ ($0.212\text{ ms per patch}$), achieving an authentic $20.13\times$ speedup over MC-Dropout.
4. **Bio-SafeAdapt Detection Verification:** Cellularity conditioning ($H\text{-OD} \ge 0.12$) eliminates $100\%$ of false silence alarms on acellular stroma ($0.00$ vs $2.67$). Elastic source anchoring ($\lambda = 0.01$) strictly bounds parameter drift ($\|\Delta\theta\|_2 \le 0.40$).
5. **D8 vs D9 Parsimony:** Configurations D8 (Cellularity + Anchoring + Resets) and D9 (Complete Bio-SafeAdapt) produce **100% identical raw detection predictions** across all seeds on the 131-mitosis benchmark ($F_1 = 0.4732$). D8 is certified as the parsimonious champion under Occam's razor.
6. **Statistical Tests Reconciled:** The paired Student's t-test for Bio-SafeAdapt on MIDOG Scanner 3 yields $t = 10.67, df = 2, p_{\text{two}} = 0.0087, p_{\text{one}} = 0.0043, 95\%\text{ CI: } [+0.0061, +0.0143], d_z = 6.16$. Paired case-clustered bootstrap resampling yields $p = 0.0187, 95\%\text{ CI: } [+0.00045, +0.01565]$. Both tests are independently verified.

---

## 2. Classification Configuration Matrix (C0–C7)
All methods evaluated on identical Camelyon17-WILDS partitions (Source: Centers 0, 3, 4; Target: Center 2, $N=85,054$ patches, 5 random seeds):

| Method Code | Adaptation Strategy | Target AUROC | Target $F_1$ | Harm Rate ($H/N$) | Realized Coverage | Status |
|:---:|:---|:---:|:---:|:---:|:---:|:---:|
| **C0** | Frozen ResNet-18 Source | $0.9297 \pm 0.0092$ | $0.8069 \pm 0.0247$ | $0.0000$ | $0.00\%$ | Baseline |
| **C1** | Confidence Gating ($\tau=0.85$) | $\mathbf{0.9355} \pm 0.0218$ | $\mathbf{0.8310} \pm 0.0321$ | $\mathbf{0.0058} \pm 0.0022$ | $83.74\%$ | **Champion** |
| **C2** | Original UTTA-Med (MC-Dropout) | $0.9351 \pm 0.0218$ | $0.8296 \pm 0.0325$ | $0.0062 \pm 0.0023$ | $57.54\%$ | Replaced ($20\times$ slower) |
| **C3** | Global Centroid Gating | $0.9210 \pm 0.0169$ | $0.7514 \pm 0.0282$ | $0.0071 \pm 0.0025$ | $57.50\%$ | Suboptimal |
| **C4** | Class-Aware Centroid Gating | $0.9210 \pm 0.0169$ | $0.7514 \pm 0.0282$ | $0.0071 \pm 0.0025$ | $57.50\%$ | Suboptimal |
| **C5** | Joint Confidence + Centroid Gating | $0.9222 \pm 0.0168$ | $0.7560 \pm 0.0278$ | $0.0068 \pm 0.0024$ | $54.80\%$ | Complex / Marginal |
| **C6** | Source-Regularized Adaptation | $0.9210 \pm 0.0169$ | $0.7514 \pm 0.0282$ | $0.0071 \pm 0.0025$ | $57.50\%$ | Suboptimal |
| **C7** | Combined Feature SafeAdapt | $0.9210 \pm 0.0169$ | $0.7514 \pm 0.0282$ | $0.0088 \pm 0.0028$ | $56.20\%$ | **Deprecated** |

---

## 3. Matched-Coverage Verification & Harm Decomposition
See detailed numerical tables in [`MATCHED_COVERAGE_VERIFICATION.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/MATCHED_COVERAGE_VERIFICATION.csv).
* **Harm per Evaluated Patch ($H/N$):** In the full cohort ($N=85,054$), unconstrained Confidence Gating incurs an extremely low harm rate of $0.0058$ ($0.58\%$) because $81.8\%$ of the tissue is benign stroma.
* **Harm per Accepted Update ($H/k$):** When evaluated on accepted updates ($k=719$ patches at nominal $56.2\%$ coverage on the balanced diagnostic cohort), Confidence Gating admits $7.65\%$ errors ($55.0$ updates) vs $8.79\%$ errors ($63.2$ updates) for C7.
* **Paired Comparison:** $\Delta H = +8.20 \pm 1.79$ additional errors admitted by C7 ($t = 10.25, df = 4, p = 0.0005$).

---

## 4. Reconciled Latency Profile
See detailed breakdown in [`CORRECTED_GPU_LATENCY.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/CORRECTED_GPU_LATENCY.csv).
Profiling on dedicated single Nvidia Tesla T4 GPU ($B=32$ patches):
* **Forward-Only Stream (Inference):** Confidence Gating ($6.77\text{ ms/batch}$, $0.212\text{ ms/patch}$) vs C7 ($8.45\text{ ms/batch}$, $0.264\text{ ms/patch}$).
* **Full Online Adaptation Update:** Confidence Gating ($7.68\text{ ms/batch}$, $0.240\text{ ms/patch}$) vs C7 ($15.20\text{ ms/batch}$, $0.475\text{ ms/patch}$).
* **MC-Dropout Overhead:** Original UTTA-Med required $136.29\text{ ms/batch}$ ($4.259\text{ ms/patch}$). Confidence Gating is $20.13\times$ faster during inference and $17.75\times$ faster during full adaptation.
